Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD Meeting Abstract
| Authors: | Domchek, S. M.; Robson, M.; Im, S. A.; Senkus, E.; Xu, B.; Masuda, N.; Delaloge, S.; Li, W.; Armstrong, A.; Conte, P.; Bannister, W.; Goessl, C.; Runswick, S.; Goel, S.; Tung, N. |
| Abstract Title: | Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD |
| Meeting Title: | 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Dec 5-9 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000425489402046 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS17-P5-21-12 |
| Notes: | Meeting Abstract: P5-21-12 -- Source: Wos |
